{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-121170","form_type":"8-K","ticker":"HLYK","cik":"0001680139","company_name":"HealthLynked Corp","filed_at":"2025-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.130806+00:00","generated_at":"2026-05-16T13:21:51.800103+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"HealthLynked appoints COO and adds two directors; targets Nasdaq uplist in 2026","bullets":["Duncan McGillivray appointed COO effective Dec 8, 2025; base salary $120K/yr, rising to $150K on Nasdaq uplist.","McGillivray receives RSU grant of up to 180K shares: 90K vest ratably over 3 years, 90K upon Nasdaq uplist.","Jason Bishara and Chris G. Pulos appointed to Board effective Dec 1, 2025; each receives $20K annual compensation in shares.","Company plans to uplist to Nasdaq Capital Market in 2026, with McGillivray overseeing capital strategy and investor relations."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-121170","json":"https://secwatch.observer/filing/0001213900-25-121170.json","markdown":"https://secwatch.observer/filing/0001213900-25-121170.md","text":"https://secwatch.observer/filing/0001213900-25-121170.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680139/000121390025121170/0001213900-25-121170-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680139/000121390025121170/ea0269326-8k_health.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:21:51.800103+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}